Omacor - News Articles

Trading FDA, Clinical Trial Binary Events: $AMRN $CXSPY $AZN | Before It's News


Ethyl-EPA is differentiated from Glaxo's (NYSE:GSK) $1 billion dollar product LOVAZA (omega-3-acid ethyl esters) in the following key areas: - potential to address a much larger patient population including those with triglyceride levels of 200-500 mg/dL vs. LOVAZA, which is indicated ...
Oslo B?rs stiger fra start - HegnarOnline


for etterspørselen fra partnere til 1.600-1.700 tonn i 2010. Dette fordi GlaxoSmithkline skal øke sin arbeidskapital, og redusere lagrene av Omacor/Lovaza. ...
Pronova kutter ettersp?rsel | Pronova BioPharma | B?rs og finans | E24


Samtidig understrekes det at Glaxo vil øke markedsføringen og at etterspørselen etter Omacor/Lovaza spås fortsette å vokse. ...
ITV News - Fish oil treatment for heart attack victims
May 23, 2007
ITV.com, UK -
concentration of omega-3-acid ethyl esters - reduces the risk of another heart attack and can cut the risk of a patient dying by up to 45 per cent. > ...
Heart Victims To Be Dosed With Fish Oil (from Evening Times)
May 23, 2007
Glasgow Evening Times, UK -
Omacor - a concentration of omega-3-acid ethyl esters - has been shown to cut the risk of a patient dying suddenly by up to 45%. ...
Scotsman.com News - Health - Heart attack patients may be prescribed fish-oil pills
May 22, 2007
Scotsman, UK -
Research has shown that a 1g highly purified concentration of omega-3 acid ethyl esters, known by the brand name Omacor, can cut by up to 45 per cent the risk of a patient dying a sudden death. Omacor is the only omega-3 supplement with a licence for post-heart ...
OnMedica - Fish oil prescription for heart attack patients
May 23, 2007
OnMedica, UK -
should consider providing at least 1g daily of omega-3-acid ethyl esters treatment licensed for secondary prevention post MI for up to four years. The new guidance contains lifestyle advice on drinking alcohol within safe limits, giving up smoking, taking regular exercise and ...
Daily Express: The World's Greatest Newspaper :: News / Showbiz :: Heart patients to have fish oil on prescription
May 23, 2007
UK Express, UK -
The pill – a 1g highly purified concentration of omega-3 acid ethyl-esters (brand name Omacor) – has been shown in clinical trials to cut the risk of sudden death by up to 45 per cent. Omacor is the only omega-3 supplement with a licence for post-heart attack ...
UK heart patients to get omega-3 on prescription?
May 23, 2007
FoodProductionDaily.com, France -
prescribing the Omacor brand of omega-3 acid ethyl-esters, currently available on prescription in the US and billed as the only FDA-approved omega-3. Such reports could have positive or negative implications, with, on the hand, the recognition of Omacor undermining the efficacy of ...
The Mountain Press
Mar 9, 2007
The Mountain Press, TN -
It includes a warning for "possible dispensing confusion between OMACOR (omega-3-acid ethyl esters) and AMICAR (aminocaproic acid). ...
Merck Ex-Exec Finds New Home
Jan 16, 2007
TheStreet.com -
By Robert Steyer. Sheares, 49, succeeds Ernest Mario, who has been chairman and CEO since 2003. Mario remains chairman, and Sheares also will become a director. Reliant sells several heart-disease related drugs, including treatments for high blood pressure and irregular heartbeat, as well ...
PharmaLive: Reliant Pharmaceuticals Names Bradley T. Sheares, Ph.D. Chief Executive Officer
Jan 16, 2007
PharmaLive.com (press release), PA -
Dr. Sheares to Succeed Ernest Mario, Ph.D. as CEO Dr. Mario to Continue as Chairman. LIBERTY CORNER, NJ, January 16, 2007 /PRNewswire/ -- Reliant Pharmaceuticals, Inc., +1-908-860-4646, investorrelations@reliantrx.comWeb site: http://www.reliantrx.com// Terms and conditions of use applyCopyright © 2007 PR Newswire Association LLC. All ...
Reliant Pharmaceuticals Names Bradley T. Sheares, Ph.D. Chief Executive Officer
Jan 16, 2007
Earthtimes.org -
LIBERTY CORNER, NJ, Jan. 16 -- Reliant Pharmaceuticals, Inc. today announced that Bradley T. Sheares, Ph.D. has been appointed Chief Executive Officer effective January 15, 2007 and will become a member of the Company's Board of Directors. Dr. Sheares succeeds ...
United Press International - Health Business - Reliant seeks use of Omacor with statins
Dec 13, 2006
United Press International -
The company said it has applied to the Food and Drug Administration for approval for Omacor -- omega-3-acid ethyl esters -- as an adjunct to diet and statin therapy in adults whose triglyceride levels are high, or in the range of 200 to 499 mg/dL. In ...
News: /C O R R E C T I O N -- Reliant Pharmaceuticals/. Genetic Engineering News - Biotechnology from Bench to Business
Dec 13, 2006
Genetic Engineering News (press release), NY -
In the news release, Reliant Pharmaceuticals Submits New Data to FDA Supporting Use of Omacor(R) (Omega-3-Acid Ethyl Esters ) With a Statin to Reduce High Triglycerides- Response Submitted to FDA for Expanded Use of Omacor - LIBERTY CORNER, N.J., Dec. 13 ...
PharmaLive: Reliant Pharmaceuticals Submits New Data to FDA Supporting Use of Omacor (Omega-3-Acid Ethyl Esters) With a Statin to Reduce High Triglycerides
Dec 13, 2006
PharmaLive.com (press release), PA -
use of Omacor(R) (omega-3-acid ethyl esters) as an adjunct to diet and statin therapy in adults whose triglyceride levels are high (200-499 mg/dL). As part of this filing, Reliant submitted new data from the recently completed COMBination of Omacor and Simvastatin (COMBOS) ...
Bolsamania - Seccin Internacional
Dec 13, 2006
Bolsamania.com, Spain -
(PRN) - Salesforce.com Helps Singapore Airlines Deploy Salesforce On-demand CRM Solution to Foster Collaboration Among Home Office-based Sales ...

Need An Omacor Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Omacor Case - Submit Your Information Below

Do you need legal assistance with your Omacor case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Omacor Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.